Therapeutic trial of sodium antimony gluconate alone and in combination with ketoconazole in post-kala-azar dermal leishmaniasis (PKDL)

Indian Journal of Dermatology, Venereology and Leprology

Volumn 69, Issue 6, 2003, Pages 392-393

  Rathi, S K ^a,b   Pandhi, R K ^a   Khanna, N ^a   Chopra, P ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NONE   (India)

Author keywords

Ketoconazole; Post kala azar dermal leishmaniasis; Sodium antimony gluconate

Indexed keywords

AMPHOTERICIN B; ANTIMONY GLUCONATE; KETOCONAZOLE; PENTAMIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEISHMANIA DONOVANI; MALE; NONHUMAN; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS; SKIN NODULE; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 33646480179     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Acton HW, Napier LE. Post-kala-azar dermal leishmaniasis. Indian Med Gaz 1929;64:147-8.
2. Anonymous. Control of the leishmaniasis. Report of a WHO Expert Committee. Tech Rep Ser No. 793. Geneva: WHO; 1990.
3. Wali JP, Aggarwal P, Gupta U, Saluja S, Singh S. Ketoconazole in the treatment of visceral leishmaniasis. Lancet 1990;336:810-11.
4. Ramesh V, Saxena U, Misra RS. Efficacy of ketoconazole in post-kala-azar dermal leishmaniasis. Arch Dermatol 1992;128:411-2.
5. El Hassan AM, Ghalib HW, Zilistra EE, et al. Post-kala-azar dermal leishmaniasis in the Sudan: clinical features, pathology and treatment. Trans R Soc Trop Med Hyg 1992;86:245-8.